DM Clinical Trials in Beijing, Beijing Municipality
11 recruitingBeijing, Beijing Municipality, China
Showing 1–11 of 11 trials
Recruiting
Phase 2
Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors
MSI-H/dMMR Solid Tumors
BeiGene200 enrolled29 locationsNCT03736889
Recruiting
Phase 3
Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema
Diabetic Macular Edema (DME)
Bio-Thera Solutions406 enrolled50 locationsNCT07515079
Recruiting
Real-world Immuno-therapy in Chinese Newly Diagnosed Multiple Myeloma Patients
Newly Diagnosed Multiple Myeloma (NDMM)
Peking University People's Hospital500 enrolled1 locationNCT07296627
Recruiting
Phase 1Phase 2
A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy.
DMD
Belief BioMed (Beijing) Co., Ltd9 enrolled1 locationNCT07058662
Recruiting
Long-term Evaluation of Gestational Endocrine & Metabolic Dynamics
Gestational Diabetes Mellitus (GDM)
Yang ZHANG800 enrolled1 locationNCT07119177
Recruiting
Not Applicable
Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients
T2DMT2DM (Type 2 Diabetes Mellitus)Type 2 Diabetic Patients
Beijing Hospital115 enrolled16 locationsNCT03987308
Recruiting
The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy
T2DMDiabetic Nephropathy
Chinese PLA General Hospital2,000 enrolled1 locationNCT06843304
Recruiting
Phase 3
A Study of BGM0504 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise
Type 2 Diabetes Mellitus (T2DM)
BrightGene Bio-Medical Technology Co., Ltd.207 enrolled1 locationNCT06716203
Recruiting
Phase 3
A Study of BGM0504 in Participants with Type 2 Diabetes
Type 2 Diabetes Mellitus (T2DM)
BrightGene Bio-Medical Technology Co., Ltd.537 enrolled1 locationNCT06716216
Recruiting
Phase 2
Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers
Gastric CancerColon CancerMSI-H+1 more
Peking University38 enrolled1 locationNCT06580574
Recruiting
Phase 2
Cadonilimab in Locally Advanced MSI-H/dMMR Colorectal Cancer
dMMR Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences50 enrolled1 locationNCT05815290